[
In December 2011, the Advisory Committee on Immunization Practices of the
Centers for Disease Control and
Prevention and the American Academy of Pediatrics (AAP) updated recommendations
for the meningococcal vaccine and booster dose.1
Updated recommendations include vaccinating adolescents at 11 or 12 years with
the quadrivalent meningococcal
vaccine and administering a booster dose at age 16 with the objective of
protecting adolescents and young adults
between 16 and 21 years when meningococcal disease rates peak.
The complete list of updated guidelines is available online in the journal
Pediatrics.
The third-party websites mentioned in this
publication are maintained by organizations over which AmeriHealth exercises no
control, and accordingly, AmeriHealth disclaims any responsibility for the
content, the accuracy of the information, and/or quality of products or
services provided by or advertised in these third-party sites. URLs are
presented for informational purposes only. Certain services/treatments referred
to in third-party sites may not be covered by all benefits plans. Members
should refer to their benefits contract for complete details of the terms,
limitations, and exclusions of their coverage.
]